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Intrinsic factor is produced primarily by chief cells in
rat and mouse, but 4 to 11% of isolated rat parietal
cells also contain intrinsic factor. To test whether
local conditions could alter the distribution of intrin-
sic factor expression, two rodent models of chronic
lymphocytic gastric inflammation were examined.
Immunocytochemistry was performed using anti-
serum against human intrinsic factor and H/K ATPase
(a parietal cell marker), counting the percent of in-
trinsic factor-positive parietal cells. HLA-B27 trans-
genic rats develop chronic gastritis at age 3 months.
Congenic controls expressed intrinsic factor in 8.9 6
3.8% (mean 6 SD) of parietal cells; in inflamed areas
of transgenic rats 21 6 5.2% (P < 0.0001) of parietal
cells were positive. In adjacent areas without inflam-
matory infiltrate 16 6 3.6% of parietal cells contained
intrinsic factor. C57BL/6 mice inoculated with Helico-
bacter felis develop gastritis by 4 weeks. After 4 and 8
weeks of infection, intrinsic factor-positive parietal
cells increased from 7.8 6 2.8% in the congenic con-
trols to 17.6 6 4.1% in the inflamed gastric body (P <
0.0001). Isolated rat parietal cells incubated with in-
terleukin-1b demonstrated a twofold increase in in-
trinsic factor-positive parietal cells. These studies are
consistent with the concept that intrinsic factor
expression is both predetermined in chief cells and
can be expressed in parietal cells in response to
local inflammatory factors. The differences be-
tween inflamed and adjacent noninflamed areas in
the rat model suggest a tissue gradient of soluble
inducer(s) , possibly cytokines. (Am J Pathol 2000,
157:1197–1205)
Gastric glands in the zymogenic region of the stomach
contain three major cell types: mucous surface cells,
parietal cells, and zymogenic (chief) cells.1 Intrinsic fac-
tor (IF) is a major secreted protein of the parietal cells in
humans,2 but in the mouse and rat IF is found in the
zymogenic cells.3,4 In human5 and in rat gastric mucosa,
IF is occasionally found inside cells of different lineage,
especially in the rat in which 4 to 11% of isolated parietal
cells express the protein.6 These IF-expressing parietal
cells were distributed in the lower neck and basal regions
of the gastric glands, consistent either with predetermi-
nation of expression within cell lineages, with parietal cell
maturation, with induction of IF production by local tissue
factors, or with a combination of these mechanisms. Lo-
cal factors may account for the phenomenon of mosa-
icism noted in small intestinal epithelium.7,8 A number of
cytokines, especially interleukin (IL)-1b and tumor necro-
sis factor (TNF)-a, can induce protein production in so-
matic cells.9,10 Moreover, IL-1 receptors are found on the
surface of parietal cells.11 Therefore, models of chronic
inflammation of the zymogenic mucosa were selected to
test whether increased elaboration of cytokines could
enlarge the population of parietal cells that produce IF.
HLA-B27, a serologically defined class 1 major histo-
compatibility complex allele, is associated with several
human inflammatory disorders. An attempt was made to
produce an animal model in transgenic mice, but despite
physiologically normal function of B27 in hybrid mice, no
features of human disease appeared.12 Because rats are
susceptible to experimental arthritis that cannot be pro-
duced in mice, transgenic technology was developed in
Fisher 344 and Lewis rats, and animals expressing HLA-
B27 and human b2-microglobulin genes developed
spontaneous multiorgan inflammatory disease.13 Two of
the seven transgenic lines developed inflammation, in-
cluding gastrointestinal disease and arthritis, increasing
in severity from 5 to 15 weeks of age. F344 transgenic
rats raised in a specific pathogen-free environment de-
velop histological evidence of colitis and gastroduodenal
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inflammation by 10 to 12 weeks of age. No disease
occurs in the absence of bacterial stimulation14 and dis-
ease correlates with cecal luminal anaerobic bacterial
concentrations.15 The incidence of disease varied from
30 to 100% in litters, and was affected by the genetic
strain and density of animals/cage. The gastric body and
antrum were involved with widely scattered mononuclear
foci in the lamina propria and submucosa. The infiltrate
occurred in some, but not all, crypt units, and was asso-
ciated with a marked reduction in the number of parietal
cells in some glands.13 Subsequently the model was
reproduced in transgenic mice (mostly males), where it
was associated with the presence of free heavy chains on
a subpopulation of B27-expressing lymphocytes.16 In
this model inflammation did not develop in germ-free
animals, although no pathogen was detected in the gas-
trointestinal lumen.
Helicobacter pylori infection causes clinical gastritis
and peptic ulcers and is associated with the develop-
ment of gastric cancer. Helicobacter felis is a spiral bac-
teria isolated from feline stomach that colonizes gastric
mucosa in mice, rats, and dogs.17 H. felis-associated
gastritis in mice reproduces many of the features of hu-
man disease, including a marked polymorphonuclear
and mononuclear cell infiltrate.18 Production of H. felis
infection in C57BL/6 mice was achieved by inoculating
mice orally, and observing a similar infiltrate with a
marked reduction in parietal cells noted by 6 months of
infection.19 The organism colonizes the gastric mucous
layer and causes gastritis in the antrum and body of the
stomach by 4 weeks, with inflammation increasing further
by 8 weeks after inoculation.20
These animal models were used to test the hypothesis
that chronic inflammation could increase ectopic IF pro-
duction in other gastric cell lineages, particularly the
parietal cell that expresses IF in human mucosa. Despite
the decrease in parietal cell populations that occurred
during development of inflammation, both models dem-
onstrated more than a twofold increase in the percent of
parietal cells that expressed IF, but only when an inflam-
matory infiltrate was present in the tissue. Other gastric
mucosal lineages did not express IF. These results are
consistent with a cytokine-induced expression of IF in
parietal cells, and suggest that IF expression in cells is
not entirely predetermined, at least in certain subpopu-




A colony of transgenic HLA-B27 rats and nontransgenic
littermates were derived in a sterile environment at the
University of North Carolina School of Medicine, popu-
lated with specific pathogen-free bacteria (documented
Helicobacter sp. free), and maintained in that environ-
ment.15 The colony, derived from specific pathogen-free
inbred Lewis/CrlBR (LEW) rats, was originally obtained
from Dr. Joel D. Taurog (Southwestern Medical School,
Dallas, TX). Female C57BL/6 mice, purchased from Tac-
onic Laboratories (Germantown, NY), were inoculated
intragastrically three times on alternate days at 5 weeks
of age with 1 3 109 cfu of H. felis (ATCC 49179).
Tissues
Transgenic and control rats were killed at 1, 2, or 3
months of age. H. felis inoculated mice were maintained
for up to 4 weeks after infection.18 After rats or mice were
euthanized with CO2 inhalation, the glandular rat stom-
achs were fixed in Bouin’s solution for 2 hours at room
temperature, and transferred to 70% ethanol overnight at
4°C before embedding in paraffin. The body and antrum
of the murine stomachs were fixed in 10% buffered for-
malin for a few hours, stored in 80% ethanol, and then
embedded in paraffin. Sections were cut 4-mm thick and
stained for hematoxylin and eosin (H&E), or used for
immunocytochemistry. Inflammatory infiltrate was esti-
mated as absent, moderate, or severe (0, 1, or 11)
by one observer (J-SS) in a blinded manner. These sam-
ples were obtained from the same animals reported
previously.20
Immunocytochemistry
Immunostaining was performed using the standard avi-
din-biotin-peroxidase complex method as reported pre-
viously,6 and counterstained with hematoxylin. Endoge-
nous peroxidase was quenched by pretreatment with 1%
H2O2 in methanol for 20 minutes. The primary antiserum
used was rabbit polyclonal anti-human IF (1:200), raised
against recombinant human IF produced in baculovirus-
infected Sf9 cells.5 In some experiments recombinant
purified human IF made in Pichia pastoris was added to
the antiserum before adding to the section.21 Rabbit an-
tibody against the b-subunit of rat H/K ATPase (amino
acids 2 to 23) was obtained from Dr. Jeffrey I. Gordon
(Washington University School of Medicine, St. Louis,
MO). Second antibody was goat anti-rabbit IgG obtained
from Vector Laboratories (Burlingame, CA). Parietal cells
were identified by their large size, triangular shape, and
different staining pattern compared with chief cells.
Quantitation of parietal cells staining positively for IF was
performed manually. All parietal cells in sections of rat
and mouse stomachs were counted in eight 3200 mag-
nified fields per section, prepared from four rats and
three mice per group/time point. The mean 6 SD values
were compared by Student’s t-test of paired samples.
Parietal Cell Incubation
Highly enriched preparations of parietal cells were iso-
lated from rat gastric mucosa as described previously,6
and cultured for 24 to 48 hours.11 Enriched preparations
of parietal cells were washed 3 times in serum-free cul-
ture medium, and cells were cultured for 48 hours in a 1:1
mixture of Ham’s F-12 medium/Dulbecco’s modified Ea-
gle’s medium with HEPES plus L-glutamine without bicar-
bonate, and supplemented with insulin (5 mg/ml), trans-
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ferrin (5 mg/ml), sodium selenite (5 ng/ml), hydrocortisone
(4 mg/ml), epidermal growth factor (25 ng/ml), gentami-
cin (10 mg/100 ml), and bovine serum albumin (2 mg/
ml).11 Thereafter, recombinant human IL-1b (2.5 pg/ml)
or recombinant human interferon-g (1.5 ng/ml) were
added to fresh culture media without added growth fac-
tors for 4 hours at 37°C. The medium was aspirated,
centrifuged, and stored at 220°C. Adherent cells were
removed by trypsinization, washed in phosphate-buff-
ered saline (PBS), centrifuged, and fixed in Bouin’s solu-
tion overnight before transfer to graded ethanol concen-
trations from 70 to 100%. The cells were embedded in
paraffin and 5-mm sections of the cell pellet were pre-
pared on slides, which were probed with antiserum
against IF as described above. The cells on each slide
were counted completely, each high-power field con-
tained 108 to 384 parietal cells (total of 1773 to 4384 in
each slide were counted), and the IF-positive cells re-
Figure 1. Immunocytochemical specificity for IF antiserum. Samples from control 3-month-old rats were processed and analyzed as described in Methods. A:
Gastric body, showing IF-positive cells, mostly chief cells in the lower 2/3 of the glands (anti-IF 1:200; original magnification, 3250). B: Gastric body with control
serum, showing no reactivity compared with A (normal rabbit serum 1:200; original magnification, 3250). C: Gastric body, showing IF-positive cells concentrated
in chief cells at the base of the glands, with lesser reaction in parietal cells (anti-IF 1:200; original magnification, 3500). D: Gastric body using anti-human IF
incubated with recombinant IF 12.8 mg/mL overnight at 4°C. Two hundred ml of the 1:200 dilution of antibody contained 1.7 mg of IF. Note that compared with
C reactivity was completely inhibited (original magnification, 3500).




Inflammation Parietal cells/magnified field
(mean no. 6 SD)
IF-positive parietal cells
(mean% 6 SD)Body Antrum
Controls (4) 3 2 2 110 6 27 8.9 6 3.8
Transgenic (4) 1 2 2 122 6 32 9.6 6 5.6, P 5 0.6
Transgenic (4) 2 2 1 100 6 23 9.2 6 4.4, P 5 0.7
Transgenic (4) 3 1 1
Non-inflamed areas 116 6 38 16 6 3.6, P , 0.0001*
Inflamed areas 77 6 19 21 6 5.2, P , 0.0001*
*P by paired two-sample t test for means (with equal variance) of 3 month inflamed versus noninflamed areas. The gender of animals (male/female)
was 0/4 for controls, 4/0 for 1-month-old transgenics, and 2/2 for 2- and 3-month-old transgenics.
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Transgenic animals were studied at 1, 2, or 3 months of
age. Congenic control animals were examined only at 3
months of age. In the gastric body of the control rats,
8.9% of the parietal cells were positive for IF (Table 1 and
Figure 1). Figure 1 demonstrates the specificity of the
antiserum used against IF. Neither normal rabbit serum
(Figure 1B) nor anti-IF antiserum incubated with recom-
binant IF (Figure 1D) showed any reactivity in either chief
cells or parietal cells.
The percent of positive cells in transgenic HLA-B27
rats at 1 and 2 months of age (9.6 and 9.2, respectively)
was no different from that found in the gastric body of
control rats (Table 1). There was no inflammation found in
the body of these animals, although mild inflammation
had developed in the antrum by 2 months of age. No
parietal cells are found in the antrum of adult rats, how-
ever, and stains for IF were also negative. After 2 months
the infiltrate in the gastric body was not uniform, involving
some gastric glands, but not others (Figure 2A). By 3
months submucosal abscesses were found occasionally
in the antrum, and in the body more extensive inflamma-
tion with dilation of the gastric pits (Figure 2B). This
inflammation was mononuclear (Figure 2C). In control
rats the IF-positive parietal cells were mostly located in
the lower part of the crypt (Figure 2D).
The findings in the 3-month-old transgenic rats were
quite different. Chronic (lymphocytic) inflammation and
mucosal hyperplasia was found in both the body and
antrum of the stomach (Figure 2, A and B). The absolute
number of parietal cells was decreased.17 Control rats
had 110 6 27 (mean 6 SD) parietal cells per magnified
field (n 5 32), whereas inflamed areas in transgenic rats
showed 77 6 19 parietal cells (n 5 32). In the inflamed
glands, 21% of parietal cells were IF-positive. Most of the
positive cells were found in the lower neck and basal
regions of the glands, and none appeared to be dying or
apoptotic cells. In adjacent glands that were not inflamed
there were still 16% of parietal cells that were positive for
IF (Figure 2, E and F, and Table 1). These values were
significantly greater than that for the control rats. In ad-
dition, the inflamed glands and those adjacent to them
were also different from each other (P , 0.0001).
The identity of IF-positive cells with morphology-like
parietal cells was confirmed using antiserum against H/K
ATPase, a parietal cell marker. Figure 2G shows all pari-
etal cells positive in a 3-month-infected transgenic ani-
mal. Figure 2H shows an adjacent section stained with
antiserum against IF, demonstrating some cells positive
for both markers (isolated arrows), and some parietal
cells positive for H/K ATPase but negative for IF.
H. felis Model
After either 4 or 8 weeks of infection, the mucosa and the
submucosa both showed inflammatory infiltration, al-
though the degree and distribution of inflammation was
somewhat variable. After 4 weeks the parietal cell density
in some gastric glands was decreased, and scattered
inflammatory cells were found in the mucosa of the gas-
tric body (Figure 3, B compared with the control in A). The
number of parietal cells seen in H&E sections was dimin-
ished by 8 weeks (see Figure 3C versus Figure 1,A and
B).20 Control mice (n 5 six animals, 70 fields) showed
70 6 29 parietal cells/magnified field compared with the
value in infected mice (n 5 6, 62 fields) of 50 6 41, but no
mucosal hyperplasia was noted as in the HLA-B27 rat
model. Moreover, submucosal inflammation was present,
and atrophic parietal cells were noted by their smaller
size and diminished eosinophilic stain. These cells were
seen mostly in the middle part of the gastric gland (Figure
3, C and E). Further analysis of these atrophic cells was
made using antiserum against H/K ATPase. In the normal
control mice, all parietal cells stained strongly positive
(Figure 3D). In the 8-week-infected mice, on the other
hand, the stain for H/K ATPase is much diminished com-
pared with control tissues, and some cells that appear by
morphology to be atrophic parietal cells are negative
(Figure 3E).
The percent of IF-positive cells doubled in the pres-
ence of inflammation (Table 2), and did not change from
4 to 8 weeks (P 5 0.49). However, the degree of mucosal
inflammation did not alter qualitatively either (compare
Figure 3, B and C). Again, the increase in IF-positive cells
was located primarily in the lower neck and basal regions
of the gastric glands and these cells seemed normal
morphologically (Figure 3, F–H).
Isolated Rat Parietal Cells
The percent of IF-positive parietal cells incubated with
the cytokine interleukin-1b increased from 3.14 6 1.41%
Figure 2. Gastric histopathology and immunocytochemistry in HLA-B27 transgenic rats. A: Gastric tissue from a 2-month-old transgenic rat. Note antral
inflammation in the left panel (arrowheads) (H&E; original magnification, 3250). The mucosa of the gastric body (right) showed no inflammation (H&E;
original magnification, 3500). B: Stomach from 3-month-old transgenic rat. The left panel shows antrum with focal inflammatory infiltration at the base of the
glands (H&E; original magnification, 3125). The right panel shows gastric body with inflammatory infiltrate (arrowheads) with marked dilatation of pits and
glands (asterisk; original magnification, 3250). C: Gastric body from 3-month-old transgenic rat. The inflammatory infiltrate is primarily lymphocytic
(arrowheads) and monocytic (arrow) (H&E; original magnification, 3500). D: Immunocytochemistry (IF) of gastric body from 3-month-old control rat. Note
that IF-positive cells are primarily confined to the lower parts of the crypt, and are less numerous than in E (anti-IF 1:200; original magnification, 3500). E and
F: Immunocytochemistry (IF) of gastric body from 3-month-old transgenic rat. Note that IF-positive cells are more numerous (arrowheads) immediately next to
inflammatory areas (asterisk) and less so in adjacent noninflamed areas, but more than in tissue from control animals (D) (anti-IF 1:200; original magnifications,
3250, 3500). G: Immunocytochemistry (H/K ATPase) of gastric body of 3-month-old transgenic rat, showing that all parietal cells (and no chief cells) were
reactive (anti-H/K ATPase 1:200; original magnification, 3500). H: Immunocytochemistry (IF) of the section adjacent to G, showing that some parietal cells are
positive for both IF and H/K ATPase (see isolated arrows in G and H) (anti-IF 1:200; original magnification, 3500). cc, chief cells; pc, parietal cells.
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to 6.35 6 4.05% (mean 6 SD, P , 0.005, n 5 17). On the
other hand, incubation with interferon-g produced a small
decline in IF-reactive cells, from 1.83 6 1.19% to 0.96 6
0.85% (n 5 10, P , 0.1). No difference in IF appearance
in the medium was detected between control and cyto-
kine-incubated cells.
Discussion
The findings in the control animals of both models con-
firms our earlier observations that IF was expressed in
parietal cells of the gastric mucosa in rodents.6 The per-
cent of IF-positive cells in the control groups was higher
than found in outbred Sprague-Dawley rats (1.5 to 4%),
but consistent with the percent of IF-positive parietal cells
in isolated parietal cell preparations (4 to 11%).6 Previous
studies of IF expression in mice using the same anti-
serum were unable to detect IF in parietal cells, although
a different strain of mice was used, and the tissues were
fixed for extended periods of time (usually days) before
being analyzed.4 It had been appreciated that IF is very
sensitive to loss of antigenicity during fixation for electron
microscopic findings,22 but it was not so clear that the
same problem existed for light microscopic studies. Per-
haps the small size of the murine tissue requires shorter
fixation times. We routinely use only a few hours for
fixation of gastric tissue before immunolocalization stud-
ies and find that time quite sufficient for adequate tissue
preservation.
The finding of ectopic production of IF, especially lo-
cated in the lower neck and basal regions of the gastric
gland, suggests that the expression of chief cell products
in parietal cells is either hard-wired (predetermined by
lineage or by functional maturation), or is influenced by
environmental factors. The increase in IF-positive parietal
cells in two models of chronic inflammation of the gastric
body suggests that local environmental factors may be
important. The rat model demonstrates gastric mucosal
hyperplasia, whereas in the mouse model patches of
atrophic mucosa are seen without intervening hyperpla-
sia. Both models cause a marked decrease in the total
number of parietal cells, and some of the remaining pa-
rietal cells in the middle of the murine gastric glands were
atrophic. It seems unlikely that IF expression is solely a
measure reflecting cell damage, as none of the IF-posi-
tive cells in or near the base of the gastric glands ap-
peared abnormal morphologically. In addition, H. felis
infection of C57BL6 mice show a marked diminution in
chief cell number with a decrease in IF immunostaining.23
It is possible that the proliferative zone containing rel-
atively undifferentiated cells is expanded whether muco-
sal hyperplasia or atrophy is present. For example, in the
presence of inflammation the parietal cell precursors ca-
pable of IF expression (eg, preneck precursor lineage in
the mouse,1 might be preferentially preserved, creating a
falsely elevated percent of IF-positive cells. However, in
relatively normal gastric glands adjacent to the inflamed
ones (in the rat model) the percent of IF-positive cells was
also higher, although the number of parietal cells seemed
normal. Thus, it seems unlikely that preservation of an IF-
expressing lineage accounts for the observed changes.
The most likely explanation for these findings induced
by inflammation is that they are related to recruitment of
parietal cells newly expressing IF. The IF-positivity was
present only when the gastric body is inflamed and the
percent of positive cells was higher in inflamed areas
than in noninflamed glands, at least in the rat model that
allows such comparisons. Moreover, the difference be-
tween inflamed and noninflamed areas suggests a gra-
dient effect, consistent with the presence of a diffusible
inducer, perhaps secreted by (or liberated from) infiltrat-
ing inflammatory cells. The inflammation might be related
either to a primary effect on the mucosa or a secondary
one mediated by microbial presence and stimulation.15




Inflammation IF-positive parietal cells
(mean % 6 SD)Mucosa Submucosa
Control (6) 4/8 2 2 7.8 6 2.8
H. felis (3) 4 1/11 1 17 6 4.9, P , 0.0001*
H. felis (3) 8 1/11 11 17.2 6 3.2, P , 0.0001*
H. felis (6) 4/8 17.6 6 4.1, P , 0.0001*
All animals were females. *P value by paired two-sample t test for means of infected versus control animals. The P value comparing 4-week and 8-
week infected animals was 0.49. Thus, these data were combined to provide an average value for all the infected animals (last line of table).
Figure 3. Gastric histopathology and immunocytochemistry in H. felis-infected mice. A: Gastric body from uninfected control mouse age 4 weeks. Note the normal
gastric glands (box), parietal cells, and chief cells (H&E; original magnification, 3500). B: Gastric body from 4-week-infected mouse, showing some decreased
density of parietal cells in the gastric glands (box), and scattered inflammatory infiltrate throughout the mucosa and submucosa (arrowheads) (H&E; original
magnification, 3500). C: Gastric body from 8-week-infected mouse. The left panel shows mucosal and submucosal infiltration (arrowheads) and dilated pits
and glands (asterisk). In the right panel numerous atrophic parietal cells (aPC) are seen. These are identified by their retained pyramidal shape and location
along the gastric pit, but smaller size and diminished eosinophilic staining (H&E; original magnification, 3250). D: Immunocytochemistry (H/K ATPase) of gastric
body of 8-week control mouse, showing that all parietal cells, but no chief cells, were reactive (anti-H/K ATPase 1:300; original magnification, 3500). E:
Immunocytochemistry (H/K ATPase) of a section adjacent to C from an 8-week-infected mouse. Numerous atrophic parietal cells are seen that are immunoreactive
(arrowheads), but less strongly when compared to normal parietal cells in D. Some H/K ATPase-negative atrophic parietal cells are seen (arrows) (anti-H/K
ATPase 1:300; original magnification, 3500). F: Immunocytochemistry (IF) of gastric body of 4-week control (left) and 4-week-infected (right) mice. In control
mice nearly all IF-positive cells are chief cells, but after infection more parietal cells are positive (anti-IF 1:200; original magnification, 3500). G: Immunocyto-
chemistry (IF) of gastric body of an 8-week control animal, showing only a few IF-positive parietal cells and many negative ones (anti-IF 1:200; original
magnification, 3500). H: Immunocytochemistry (IF) of gastric body of an 8-week-infected mouse, showing increased IF-positive parietal cells, with surrounding
inflammation (anti-IF 1:200; original magnification, 3500). pc, parietal cells; cc, chief cells.
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The cytokines produced by inflammatory cells that
have been often associated with increased protein ex-
pression are IL-1, TNF-a, and interferon-g. The mRNAs
encoding these cytokines (among others) are abundantly
expressed in the gastric mucosa of patients with chronic
gastritis,24 and expression is increased in the inflamed
colons of HLA-B27 transgenic rats.15 Gastric parietal
cells have receptors for IL-1 at least, and this cytokine
has been demonstrated to have antisecretory activi-
ty.11,25 IL-10 and TNF-a production26 and IL-1b, IL-6,
IL-8, and IL-12 as well,27 are increased in antral mucosal
biopsies from patients with chronic gastritis, and the cy-
tokine secretion varies with the degree of inflammation.26
IL-8 and TNF-a production were increased in patients
with H. pylori infection in one study,28 but not in another.27
The studies with isolated parietal cells showed that at
least one cytokine that contributes to a Th1 response
(IL-1b) reproduced in vitro the twofold increase in IF-
positivity seen in vivo. Atrophy of parietal and zymogenic
cells is an eventual outcome of chronic inflammation of
the gastric body, but dysplasia precedes the atrophy in
most cases. The altered IF expression might be an early
marker of such dysplastic changes.
It is possible that the observed increase in IF immuno-
reactivity is related to a decrease in IF secretion, as IF
and H1 secretion occur by the same canalicular path-
way.22 For this explanation to be valid, it would be
necessary for some parietal cells to be producing unde-
tectable IF under basal conditions. Alternatively, the cy-
tokines released during inflammation could up-regulate
expression of IF in cells which constitutively express un-
detectable amounts, recruit new cells to produce IF, ex-
pand a population of parietal cells that normally produce
IF, or have combined effects. The results with isolated
parietal cells favor up-regulation of IF expression.
This study did not evaluate the quantitative secretion of
IF from chief cells, although there was no obvious change
in their immunoreactivity (Figures 2 and 3). IL-1b, on the
other hand, does not affect basal or stimulated pepsino-
gen secretion from chief cells.29 Whatever the mecha-
nism whereby cytokines may produce the effect noted on
parietal cells, it is possible that increased IF-positivity
represents a surrogate marker for the local effect of one
or more cytokines. If so, this would be very instructive in
following the tissue effects of cytokine stimulation and in
evaluating this response as a marker for eventual muco-
sal atrophy.
Acknowledgment
We thank Feng-Ling Li for providing excellent technical
support for the HLA-B27 studies.
References
1. Karam SM, Leblond CP: Identifying and counting epithelial cell types
in the “corpus” of the mouse stomach. Anat Rec 1993, 236:259–279
2. Glass GBJ: Gastric Intrinsic Factor and Other Vitamin B12 Binders.
Stuttgart, Georg Thieme Publications, 1974
3. Boass A, Wilson TH: Cellular localization of gastric intrinsic factor in
the rat. Am J Physiol 1964, 206:783–786
4. Lorenz RG, Gordon JI: Use of transgenic mice to study regulation of
gene expression in the parietal cell lineage of gastric units. J Biol
Chem 1993, 268:26559–26570
5. Howard TA, Misra DN, Grove M, Becich MJ, Shao J-S, Gordon MM,
Alpers DH: Human gastric intrinsic factor expression is not restricted
to parietal cells. J Anat 1996, 189:303–313
6. Shao J-S, Schepp W, Alpers DH: Expression of intrinsic factor and
pepsinogen in the rat stomach identifies a subset of parietal cells.
Am J Physiol 1998, 274:G62–G70
7. Mauiri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R, Finzi G,
Cornaggia M, Capella C, Quaroni A, Auricchio S: Mosaic pattern of
lactase expression by villous enterocytes in human adult-type hyplac-
tasia. Gastroenterology 1991, 100:359–369
8. Rubin D, Ong DE, Gordon JI: Cellular differentiation in the emerging
fetal rat small intestinal epithelium: mosaic patterns of gene expres-
sion. Proc Natl Acad Sci USA 1989, 86:1278–1282
9. Dinarello CA: Biology of interleukin-1. FASEB J 1988, 2:108–115
10. Dayer JM, Beutler B, Cerami A: Cachectin/tumor necrosis factor
stimulates collagenase and PGE2 production by human synovial cells
and dermal fibroblasts. J Exp Med 1985, 162:2163–2168
11. Schepp W, Dehne K, Herrmuth H, Pfeffer K, Prinz C: Identification and
functional importance of IL-1 receptors on rat parietal cells. Am J
Physiol 1998, 275:G1094–G1105
12. Taurog JD, Lowen L, Forman J, Hammer RE: HLA-B27 in inbred and
non-inbred transgenic mice. Cell surface expression and recognition
as an alloantigen in the absence of human b2-microglobulin. J Im-
munol 1988, 141:4020–4023
13. Hammer RE, Maika SD, Richardson JA, Tang J-P, Taurog JD: Spon-
taneous inflammatory disease in transgenic rats expressing HLA-B27
and human b2m: an animal model of HLA-B27-associated human
disorders. Cell 1990, 63:1099–1112
14. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr, Balish E,
Taurog JD, Hammer RE, Wilson KH, Sartor RB: Normal luminal bac-
terial, especially Bacteroides species, mediate chronic colitis, gastri-
tis, and arthritis in HLA-B27/human beta2 microglobulin transgenic
rats. J Clin Invest 1996, 98:945–953
15. Rath HC, Ikeda JS, Linde H-J, Schomerich J, Wilson KH, Sartor RB:
Varying cecal bacterial loads influences colitis and gastritis in HLA-
B27 transgenic rats. Gastroenterology 1999, 116:310–319
16. Khare SD, Hansen J, Harvinder SL, David CS: HLA-B27 heavy chains
contribute to spontaneous inflammatory disease in B27/human b2-
microglobulin (b2m) double transgenic mice with disrupted mouse
b2m. J Clin Invest 1996, 98:2746–2755
17. Lee A, Fox JG, Murphy J: A small animal model of human Helicobacter
pylori active gastritis. Gastroenterology 1990, 99:1315–1323
18. Fox JG, Blanco M, Murphy JC, Taylor NS, Lee A, Kabok Z, Pappo J:
Local and systemic immune responses in murine Helicobacter felis
active chronic gastritis. Infect Immun 1993, 61:2309–2315
19. Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, Wang TC:
Hypertrophic gastropathy in Helicobacter felis-infected wild-type
C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterol-
ogy 1996, 110:155–166
20. Lichtenberger LM, Dial EJ, Ottlecz A, Romero JJ, Lechago J, Fox JG:
Attenuation of the hydrophobic phospholipid barrier is an early event
in Helicobacter felis-induced gastritis in mice. Dig Dis Sci 1999, 44:
108–115
21. Wen J, Kinnear MB, Richardson MA, Willetts NS, Russell-Jones GJ,
Gordon MM, Alpers DH: Functional expression in Pichia pastoris of
human and rat intrinsic factor. Biochim Biophys Acta 2000, 1490:
43–53
22. Levine JS, Nakane PK, Allen RH: Human intrinsic factor secretion:
immunocytochemical demonstration of membrane associated vesic-
ular transport in parietal cells. J Cell Biol 1981, 90:644–655
23. Wang TC, Goldenring JR, Dangler C, Ito S, Mueller A, Jeon WK, Koh
TJ, Fox JG: Mice lacking secretory phospholipase A2 show altered
apoptosis and differentiation with Helicobacter felis infection. Gastro-
enterology 1998, 114:675–689
24. Ishihara S, Fukuda R, Fukumoto S: Cytokine gene expression in the
gastric mucosa: its role in chronic gastritis. J Gastroenterol 1996,
31:485–490
1204 Shao et al
AJP October 2000, Vol. 157, No. 4
25. Tache Y, Saperas E: Potent inhibition of gastric acid secretion and
ulcer formation by centrally and peripherally administered interleu-
kin-1. Ann NY Acad Sci 1992, 664:353–368
26. Bodger K, Wyatt JI, Heatley RV: Gastric mucosal secretion of
interleukin-10: relations to histopathology, Helicobacter pylori status,
and tumour necrosis factor-alpha secretion. Gut 1997, 40:739–744
27. Bauditz J, Ortner M, Bierbaum M, Niedobitek G, Lochs H, Schreiber
S: Production of IL-12 in gastritis relates to infection with Helicobacter
pylori. Clin Exp Immunol 1999, 117:316–323
28. Fan XG, Chua A, Fan XJ, Keeling PW: Increased gastric production of
interleukin-8 and tumour necrosis factor in patients with Helicobacter
pylori infection. J Clin Pathol 1995, 48:133–136
29. Serrano JT, Lanas AI, Lorente S, Sainz R: Cytokine effects on pep-
sinogen secretion from human peptic cells. Gut 1997, 40:42–48
Intrinsic Factor in Inflammatory Animal Models 1205
AJP October 2000, Vol. 157, No. 4
